Search Results
Baxter to Host Its Annual Meeting of Stockholders in Virtual Format
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that, due to the public health and safety concerns related to the novel coronavirus (COVID-19) pandemic, its Annual Meeting of Stockholders (the 2021 Annual Meeting) will again be held by means of a virtual format only.
Baxter Launches Initiative to Increase Awareness and Education in Black Communities About Kidney Health and Managing Chronic Kidney Disease
Baxter International Inc. (NYSE:BAX), a leading global medical products company, and the Central Area of The Links, Incorporated, an international not-for-profit comprised of 16,000 women of color, announce a new partnership to bring awareness and resources to the disproportionate challenges affecting Black Americans related to kidney health. Through the partnership, Baxter is committing $600,000 to fund grants to local Links chapters in the organization’s 17-state U.S.
Baxter to Host First-Quarter 2021 Financial Results Conference Call for Investors
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its first-quarter 2021 financial results on Thursday, April 29, 2021 at 7:30 a.m. Central Time. To participate in this conference call please follow this link http://www.directeventreg.com/registration/event/1693119 to pre-register for the call and receive the call information.
Courageous, Compassionate Leadership in Healthcare’s New Era
A passion for people leadership, creative problem-solving and community engagement are at the heart of Heather’s robust career.
Fostering the Next Generation of Parenteral Nutrition Clinical Leaders
International Parenteral Nutrition Early Career Professional development grant recipient Lindsey Russell on the value of multi-disciplinary exposure
Baxter Announces U.S. FDA 510(K) Clearance of AK 98 Hemodialysis Machine
Baxter International Inc. (NYSE:BAX), a global innovator in renal care, today announced U.S. Food and Drug Administration (FDA) clearance of its next-generation Artificial Kidney 98 (AK 98) dialysis machine, which is designed to be a portable and easy-to-use system to administer hemodialysis (HD) treatments.
Baxter to Present at Oppenheimer 31st Annual Healthcare Conference
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17, 2021. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 10:40 a.m. Eastern Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through September 13, 2021.
Baxter BioPharma Solutions and Moderna Announce Agreement for Fill/Finish Manufacturing of the Moderna COVID-19 Vaccine in the U.S.
Baxter International Inc. (NYSE: BAX), a global leader in sterile medication production and delivery, and Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that they have entered into an agreement for Baxter BioPharma Solutions (BPS) to provide fill/finish sterile manufacturing services and supply packaging for approximately 60-90 million doses of the Moderna COVID-19 Vaccine in 2021.
Living Well with Kidney Disease
An estimated 850 million people have kidney disease globally; nearly 10.5 million of these individuals require dialysis or a kidney transplant.1 Each of these remarkable people have a story, a family and an adventure ahead of them; they deserve to live well with kidney disease.
Delivering Care in More Ways Than One
Baxter service specialist Pedro Perez routinely delivers life-saving and -sustaining peritoneal dialysis (PD) solutions and supplies into the homes of patients. One day late in 2020, he was called upon to take extraordinary steps to save a life.